eXoZymes Inc. (EXOZ) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for eXoZymes Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$4.22
+11.18% today
Market cap
$35M
Overall quality
42/100
Kronos AI 30-day
+77.4%
8 of 8 simulated paths end higher
eXoZymes Inc. (EXOZ) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $35M. It trades at $4.22, up 11.18% today. Its overall quality score is 42 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +77.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $6.74 (+77.4%) |
| Likely range | +60.9% … +150.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 47 |
| Growth | 44 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.